Targeted therapy of oral hairy leukoplakia with gentian violet

Journal of the American Academy of Dermatology

Volumn 58, Issue 4, 2008, Pages 711-712

  Bhandarkar, Sulochana S ^a   MacKelfresh, Jamie ^a   Fried, Levi ^a   Arbiser, Jack L ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CRYSTAL VIOLET;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; CONTROLLED STUDY; DRUG EFFICACY; EPSTEIN BARR VIRUS; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEUKOPLAKIA; PRIORITY JOURNAL; TREATMENT OUTCOME; VIRUS INFECTION;

ADULT; GENTIAN VIOLET; HIV INFECTIONS; HUMANS; LEUKOPLAKIA, HAIRY; MALE;

EID: 40649101196     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2007.11.017     Document Type: Article

References (8)

1. Greenspan J.S., Greenspan D., Lennette E.T., Abrams D.L., Conant M.A., Petersen V., et al. Replication of Epstein-Barr virus within the epithelial cells of oral "hairy" leukoplakia, an AIDS-associated lesion. N Engl J Med 313 (1985) 1564-1571
2. Niedobitek G., Young L.S., Lau R., Brooks L., Greenspan D., Greenspan J.S., et al. Epstein-Barr virus infection in oral hairy leukoplakia: virus replication in the absence of a detectable latent phase. J Gen Virol 72 (1991) 3035-3046
3. Raab-Traub N., and Webster-Cyriaque J. Epstein-Barr virus infection and expression in oral lesions. Oral Dis 3 Suppl 1 (1997) S164-S170
4. Ammatuna P., Campisi G., Giovannelli L., Giambelluca D., Alaimo C., Mancuso S., et al. Presence of Epstein-Barr virus, cytomegalovirus and human papillomavirus in normal oral mucosa of HIV-infected and renal transplant patients. Oral Dis 7 (2001) 34-40
5. Mirowski G.W., Hilton J.F., Greenspan D., Canchola A.J., MacPhail L.A., Mauser T., et al. Association of cutaneous and oral diseases in HIV-infected men. Oral Dis 4 (1998) 16-21
6. Cerimele F., Battle T., Lynch R., Frank D.A., Murad E., Cohen C., et al. Reactive oxygen signaling and MAPK activation distinguish Epstein-Barr Virus (EBV)-positive versus EBV-negative Burkitt's lymphoma. Proc Natl Acad Sci U S A 102 (2005) 175-179
7. Perry B.N., Govindarajan B., Bhandarkar S.S., Knaus U.G., Valo M., Sturk C., et al. Pharmacologic blockade of angiopoietin-2 is efficacious against model hemangiomas in mice. J Invest Dermatol 126 (2006) 2316-2322 Epub 2006 June 1
8. Walling D.M., Flaitz C.M., and Nichols C.M. Epstein-Barr virus replication in oral hairy leukoplakia: response, persistence, and resistance to treatment with valacyclovir. J Infect Dis 188 (2003) 883-890